Market revenue in 2023 | USD 324.6 million |
Market revenue in 2030 | USD 813.9 million |
Growth rate | 14% (CAGR from 2023 to 2030) |
Largest segment | Congenital heart defect (chd) closure |
Fastest growing segment | Left Atrial Appendage Closure (LAAC) |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Left Atrial Appendage Closure (LAAC), Patent Foramen Ovale (PFO) Closure, Congenital Heart Defect (CHD) Closure |
Key market players worldwide | Abbott Laboratories, W.L. Gore & Associates, Boston Scientific Corp, Cardia, LifeTech Scientific Corp, Lepu Medical, AtriCure Inc, Occlutech, Heartstitch |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heart closure devices market will help companies and investors design strategic landscapes.
Congenital heart defect (chd) closure was the largest segment with a revenue share of 57.95% in 2023. Horizon Databook has segmented the Asia Pacific heart closure devices market based on left atrial appendage closure (laac), patent foramen ovale (pfo) closure, congenital heart defect (chd) closure covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific heart closure devices market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific heart closure devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account